BioCentury
ARTICLE | Company News

FDA accepts Intermezzo NDA

December 17, 2008 2:23 AM UTC

FDA accepted for review an NDA from Transcept (Point Richmond, Calif.) for Intermezzo zolpidem to treat insomnia when a middle of the night awakening is followed by difficulty returning to sleep. The ...